Evaluation and Immediate Management of Suspected Heparin-Induced Thrombocytopenia During Heparin Prophylaxis
Suspicion for heparin-induced thrombocytopenia (HIT) should be evaluated with the 4Ts score when thrombocytopenia develops during heparin exposure. [1] In patients with intermediate- or high-probability 4Ts score, heparin should be discontinued and an alternative (non-heparin) anticoagulant should be started at therapeutic intensity when appropriate. [1]
HIT Probability Assessment Using the 4Ts Score
The 4Ts score should include the following domains. [1]
- Thrombocytopenia magnitude: platelet count fall >50% with platelet nadir ≥20 × 10^9/L; platelet count fall 30–50% or platelet nadir 10–19 × 10^9/L; platelet count fall <30% or platelet nadir <10 × 10^9/L. [1]
- Timing of platelet count fall: clear onset between days 5–14 or platelet fall ≤1 day with prior heparin exposure within 30 days; consistent with days 5–14 but not clear or onset after day 14 or fall ≤1 day with prior heparin exposure 30–100 days ago; platelet count fall ≤4 days without recent exposure. [1]
- Thrombosis or other HIT sequelae: new thrombosis confirmed, skin necrosis at heparin injection sites, an anaphylactoid reaction after IV heparin bolus, or adrenal hemorrhage; progressive or recurrent thrombosis, non-necrotizing (erythematous) skin lesions, or suspected thrombosis (not confirmed); none apparent. [1]
- Other causes of thrombocytopenia: none apparent; possible; definite. [1]
Laboratory Testing Strategy
Platelet factor 4 (PF4)/heparin immunoassay testing should be used when the 4Ts score is intermediate or high. [1] HIT laboratory testing is recommended against when the 4Ts score is low. [1] If an immunoassay is positive and a functional assay is available, a functional assay should be suggested to confirm HIT. [1]
Anticoagulation Action Based on HIT Likelihood
Heparin should be discontinued and a non-heparin anticoagulant should be initiated in acute HIT with thrombosis or acute isolated HIT. [1] For intermediate-probability 4Ts score, bleeding risk should influence anticoagulant intensity. [1]
- When intermediate-probability 4Ts score is present and there is no other indication for therapeutic-intensity anticoagulation and the patient is at high bleeding risk, anticoagulation should be initiated with a non-heparin anticoagulant at prophylactic intensity rather than therapeutic intensity. [1]
- When intermediate-probability 4Ts score is present and the patient is not at high bleeding risk or has another indication for therapeutic-intensity anticoagulation, anticoagulation should be initiated with a non-heparin anticoagulant at therapeutic intensity rather than prophylactic intensity. [1] For intermediate- or high-probability patients with a positive immunoassay, a non-heparin anticoagulant at therapeutic intensity is recommended. [1]
Selection of a Non-Heparin Anticoagulant
Non-heparin anticoagulant selection should include the following options. [1]
- Argatroban. [1]
- Bivalirudin. [1]
- Danaparoid. [1]
- Fondaparinux. [1]
- A direct oral anticoagulant (DOAC). [1]
Warfarin Avoidance and Transition Considerations
Initiation of warfarin should be avoided prior to platelet count recovery. [1] Transition from a parenteral non-heparin anticoagulant to a DOAC should be performed without required overlap. [1]
Platelet Transfusion and Bleeding-Risk Management
Routine platelet transfusion should be avoided in acute isolated HIT or acute HIT complicated by thrombosis in patients at average bleeding risk. [1] Platelet transfusion may be considered for patients with active bleeding or at high bleeding risk. [1]
Minimizing Risk of Mismanagement
HIT testing and management should not be performed for low-probability scenarios because presumptive treatment increases bleeding risk and alternative anticoagulants are costly. [2]
Ongoing Monitoring and Reassessment
The 4Ts score should be recalculated when new clinical information changes the clinical picture. [1] Frequent reassessment should be performed during the evaluation period because missing or inaccurate information can lead to a faulty 4Ts score and inappropriate management decisions. [1]